Pharmacological inhibition of the SKP2/p300 signaling axis restricts castration-resistant prostate cancer

SKP2, an F-box protein of the SCF type of the E3 ubiquitin ligase complex, plays an important function in driving tumorigenesis through the destruction of numerous tumor-suppressive proteins. Besides its critical role in cell cycle regulation, proto-oncogenic functions of SKP2 have also been shown i...

Full description

Bibliographic Details
Published in:	Neoplasia: An International Journal for Oncology Research
Main Authors:	Abdol-Hossein Rezaeian, Liem Minh Phan, Xiaobo Zhou, Wenyi Wei, Hiroyuki Inuzuka
Format:	Article
Language:	English
Published:	Elsevier 2023-04-01
Subjects:	SKP2 p300 Castration-resistant Prostate cancer Pharmacological inhibition
Online Access:	http://www.sciencedirect.com/science/article/pii/S1476558623000155

Similar Items

The SKP2‐p27 axis defines susceptibility to cell death upon CHK1 inhibition
by: Michael Lohmüller, et al.
Published: (2022-08-01)

KEDUDUKAN SURAT KETETAPAN PEMBERHENTIAN PENUNTUTAN PERKARA (SKP3) (Mengkritisi SKP3 Kasus Mantan Presiden Soeharto)
by: Umi Supraptiningsih
Published: (2019-09-01)

Downregulation of Skp2 Expression Inhibits Malignant Phenotype of Osteosarcoma U2OS Cells
by: DING Lu, et al.
Published: (2019-05-01)

SKP2 Promotes Hepatocellular Carcinoma Progression Through Nuclear AMPK-SKP2-CARM1 Signaling Transcriptionally Regulating Nutrient-Deprived Autophagy Induction
by: Xiaoshuang Wei, et al.
Published: (2018-07-01)

Skp2 expression unfavorably impacts survival in resectable esophageal squamous cell carcinoma
by: Liang Yi, et al.
Published: (2012-05-01)

Emerging Roles of SKP2 in Cancer Drug Resistance
by: Ting Wu, et al.
Published: (2021-05-01)

SKP alleviates the ferroptosis in diabetic kidney disease through suppression of HIF-1α/HO-1 pathway based on network pharmacology analysis and experimental validation
by: Yangtian Yan, et al.
Published: (2024-02-01)

SKP2 ubiquitylation modifies IDH1 to regulate hepatoblastoma cell cycle and glucose metabolism
by: Pengxiang Yu, et al.
Published: (2025-08-01)

SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies
by: Jonahunnatha Nesson George William, et al.
Published: (2024-03-01)

Effects of the skp1 gene of the SCF complex on lipid metabolism and response to abiotic stress in Chlamydomonas reinhardtii
by: Xiao Dong Deng, et al.
Published: (2025-03-01)

Genome-wide analysis of the S-phase kinase-association protein 1 (ClSKP1) family and the role of S-RNase targeting by an SCF (Cullin1-SKP1-F-box) complex in the self-incompatibility of ‘Xiangshui’ lemon
by: Yuze Li, et al.
Published: (2025-03-01)

Silybin has therapeutic efficacy against non-small cell lung cancer through targeting of Skp2
by: Shi-Bing Zhang, et al.
Published: (2022-08-01)

PD-L1 intrinsically promotes the proliferation of breast cancer cells through the SKP2-p27/p21 axis
by: Marwa Elfoly, et al.
Published: (2024-05-01)

SKP-SC-EVs Mitigate Denervated Muscle Atrophy by Inhibiting Oxidative Stress and Inflammation and Improving Microcirculation
by: Wei Wang, et al.
Published: (2021-12-01)

Chondroitin Polymerizing Factor (CHPF) promotes cell proliferation and tumor growth in human osteosarcoma by inhibiting SKP2's ubiquitination while activating the AKT pathway
by: Yi Shen, et al.
Published: (2023-09-01)

Anti-tumor effects of Skp2 inhibitor AAA-237 on NSCLC by arresting cell cycle at G0/G1 phase and inducing senescence
by: Jinyi Liu, et al.
Published: (2022-07-01)

Mechanism of baicalein in treatment of castration-resistant prostate cancer based on network pharmacology and cell experiments
by: Baokai Dou, et al.
Published: (2024-06-01)

FBXW2 suppresses proliferation and invasion of lung cancer cells by targeting SKP2 and β-catenin
by: Fei Yang, et al.
Published: (2019-07-01)

p53, SKP2 and DKK3 as MYCN target genes and their potential therapeutic significance
by: Lindi eChen, et al.
Published: (2012-11-01)

RIOK2 Inhibitor NSC139021 Exerts Anti-Tumor Effects on Glioblastoma via Inducing Skp2-Mediated Cell Cycle Arrest and Apoptosis
by: Min Yu, et al.
Published: (2021-09-01)

ARv7 promotes the escape of prostate cancer cells from androgen deprivation therapy-induced senescence by mediating the SKP2/p27 axis
by: Dian Zhuang, et al.
Published: (2025-02-01)

Mechanism of histone demethylase KDM5A in osteoporotic fracture healing through epigenetic regulation of the miR-495/SKP2/Runx2 axis
by: Zhuoran Li, et al.
Published: (2025-02-01)

Evolutionary analysis of CD300A and CD300C paired receptors in primates
by: Carolina Dias, et al.
Published: (2025-09-01)

Carbamazepine regulates USP10 through miR-20a-5p to affect the deubiquitination of SKP2 and inhibit osteogenic differentiation
by: Huan Wang, et al.
Published: (2023-11-01)

Review: castration – animal welfare considerations
by: Gabriela A. Marquette, et al.
Published: (2023-12-01)

Putative type III effector SkP48 of Bradyrhizobium sp. DOA9 encoding a SUMO protease blocks nodulation in Vigna radiata
by: Pongdet Piromyou, et al.
Published: (2025-06-01)

LEIS y SKP mapas de las etapas iniciales de corrosión localizada de AA6061-T6 en un substituto de agua de mar diluido
by: Gloria Acosta, et al.
Published: (2018-12-01)

The suppression of HSPA8 attenuates NLRP3 ubiquitination through SKP2 to promote pyroptosis in sepsis-induced lung injury
by: Jinlian Liu, et al.
Published: (2024-05-01)

Differential expression of PSMC4, SKP1, and HSPA8 in Parkinson’s disease: insights from a Mexican mestizo population
by: Alma C. Salas-Leal, et al.
Published: (2023-12-01)

Investigation of P300 evoked by Stroop Color Word Task in children with emotional neglect
by: Yang Shichang, et al.
Published: (2022-02-01)

PDCD11 Stabilizes C‐MYC Oncoprotein by Hindering C‐MYC‐SKP2 Negative Feedback Loop to Facilitate Progression of p53‐Mutant Breast and Colon Malignancies
by: Li Ding, et al.
Published: (2025-05-01)

Reduced <i>SKP2</i> Expression Adversely Impacts Genome Stability and Promotes Cellular Transformation in Colonic Epithelial Cells
by: Nicole M. Neudorf, et al.
Published: (2022-11-01)

Therapeutic targets and signaling pathways of active components of QiLing decoction against castration-resistant prostate cancer based on network pharmacology
by: Hongwen Cao, et al.
Published: (2022-06-01)

SKP2 regulates TERT independently of RUNX1/ETO in AML subtypes lacking the t(8,21) translocation via CDKN1B and RB phosphorylation states
by: Adam Azlan, et al.
Published: (2025-10-01)

DNA repair pathways-targeted cyclovirobuxine inhibits castration-resistant prostate cancer growth by promoting cell apoptosis and cycle arrest
by: Ke Gao, et al.
Published: (2023-09-01)

Prognostic value of the HALP score in metastatic castration-resistant prostate cancer: an analysis combined with time to castration resistance
by: İvo Gökmen, et al.
Published: (2024-12-01)

Creating and caring for castrates
by: Kathryn Reusch, et al.
Published: (2025-10-01)

A COPARATIVE STUDY OF CASTRATION IN PIGS
by: R. N.Al-Asadi,, et al.
Published: (1992-06-01)

Reasons for and Behavioral Consequences of Male Dog Castration—A Questionnaire Study in Poland
by: Marcelina Kriese, et al.
Published: (2022-07-01)

Post-castration syndrome: relevance, impact on quality of life, methods of correction
by: A. M. Ziganshin, et al.
Published: (2024-03-01)